期刊文献+

肾脏受累为主的抗中性粒细胞胞质抗体相关性血管炎患者的预后及其相关危险因素分析 被引量:9

Outcome and risk factors, for renal involvement in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
原文传递
导出
摘要 目的探讨肾脏受累为主的抗中性粒细胞胞质抗体(ANCA)相关性血管炎患者的预后及其影响因素。方法对2006--2008年我院诊断的64例肾脏受累为主的ANCA相关性血管炎患者进行回顾性分析,并对其进行前瞻性随访,使用Logistic回归、Cox回归等分析与患者肾脏预后有关的危险因素。结果①共入选64例患者,其中男性40例,女性24例,平均年龄(59.9±2.0)岁。随访21。55个月,平均(38±16)个月,期间34例(53%)患者出现死亡或进入长期肾脏替代治疗。②预后不同的2组患者起病时血肌酐[分别为(6±246)、(245±127)μmol/L,t=7.17,P=0.005]、红细胞沉降率(ESR)[分别为(112±24)、(76±48)mm/1h,t=3.74,P〈0.01]、血浆自蛋白[分别为(294±31)、(316±42)g/L,t=-2.27,P=O.01]、血红蛋白[分别为(79±13)、(99±33)g/L,t=-3.23,P〈0.01]差异均有统计学意义。Logistie回归及Cox回归分析证实起病时血肌酐[β=1.004,95%可信区间(CI)1.002~1.006,P〈0.01]及ESR[β=1.018,95%CI1.000~1.037,P=0.046]是预测患者预后的独立危险因素。③ROC曲线结果显示起病时血肌酐和ESR曲线下面积分别为0.95,0.80.敏感性均为94%,特异性分别为93%和70%。结论以肾脏受累为主的ANCA相关性血管炎患者预后差,起病时血肌酐水平和ESR可能是判断患者预后的重要影响因素。 Objective To investigate the outcome and risk factors for kidney involvement by analyzing 64 patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Methods Data analy- zed including the demographic information, survival status, renal survival status and laboratory parameters such as serum albumin level, serum creatinine level, urinary protein excretion level, hematuria, high sensitivity C-reactive protein (CRP), ANCA titer, and the Birmingham vasculitis activity score (BVAS). Logistic regression analysis, Cox regression analysis and ROC curve were used to evaluate the risk factors of patients with renal involvement and all-event survival. Results Totally 64 patients were enrolled [ 24 females with the average age of (59.9±2.0) years and followed up for a median of (38±16) months. The morality rate was 14%, and the prevalence of end stage renal diSease was 39%. Compared with those who had better outcomes, patients who died or with end stage renal disease had higher serum creatinine level [ (624±246), (245± 127) μmol/L, respectively, t=7.17, P=0.005] and erythrocyte sediment rate [(112±24), (76±48) mm/l h, respectively, t= 3.74, P〈0.01], but lower serum albumin level [(294±31), (316±42)g/L, respectively, t= -2.27, P=0.01 ] and hemoglobin leveI [ (79±13), (99±33) g/L, respectively, t=-3.23, P〈0.01 ] at baseiine. Logistic regression analysis found that serum creatinine level and erythrocyte sediment rate at baseline were associated with poor outcome and Cox regression analysis further confirmed this result [Scr/3=1.004, 95%CI1.002~1.006, P〈0.01; ESR fl=l.018, 95%CI 1.000-1.037, P=0.046]. ROC curve analysis showed that serum creatinine and erythrocyte sediment rate were predictors for AAV patients' prognosis and their AUC were 0.95 and 0.80, the sensitivity of these parameters was both 94%, and the specificity was 93% and 70% respectively. Conclusion The intensity of initial treatment should be based on disease severity and activity in order to improve the prognosis of those with ANCA-associated vasculitis with renal involvement. Increased serum creatinine and erythrocyte sediment rate may serve as predictors for poor prognosis in this patient cohort.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第11期754-758,共5页 Chinese Journal of Rheumatology
基金 基金项目:国家自然科学基金(81102700) 上海市科委基础重点项目(10JC1410100) 上海市高校选拔培养优秀青年教师科研专项基金(jdy09025)
关键词 血管炎 抗体 抗中性白细胞胞质 肾疾病 预后 危险因素 Vasculitis Antibody, antineutrophilcytoplasmic Kidney disease Prognosis Risk factors
  • 相关文献

参考文献15

  • 1Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis, 2011, 70: 488-494.
  • 2Itabashi M, Takei T, Yabuki Y, et al. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vas- eulitis in Japan. Nephron Clin Pract, 2010, 115 : c21-c27.
  • 3陈建,牛艳慧,李桂莲,王广发,赵明辉.抗中性粒细胞胞质抗体相关性血管炎190例临床特点分析[J].中华医学杂志,2009,89(36):2548-2551. 被引量:8
  • 4Chen YX, Yu HJ, Zhang W, et al. Analyzing fatal cases of Chi- nese patients with primary antineutrophil cytoplasmic antibodies- associated renal vasculitis: a 10-year retrospective study. Kidney Blood Press Res, 2008, 31: 343-349.
  • 5Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of sys- temic vaseulitides: proposal of an international consensus con- ference. Arthritis Rheum, 1994, 37: 187-192.
  • 6Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis, 2009, 68: 1827-1832.
  • 7Day C J, Howie A J, Nightingale P, et al. Prediction of ESRD in panci-immune necrotizing glomerulonephritis: quantitative histo- morphometric assessment and serum creatinine. Am J Kidney Dis, 2010, 55: 250-258.
  • 8Mahr A, Girard T, Agher R, et al. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granu- lomatosis and prospective follow-up. Rheumatology (Oxford), 2001, 40: 492-498.
  • 9Nakabayashi K, Arimura Y, Yoshihara K, et al. Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-cen- ter experience. Mod Rheumatol, 2009, 19: 420-426.
  • 10Frausova D, Brejnikova M, Hruskova Z, et al. Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit. Ren Fail, 2008, 30: 890-895.

二级参考文献38

共引文献8

同被引文献61

  • 1陈旻,赵明辉,刘玉春.重症原发性ANCA相关性小血管炎[J].世界急危重病医学杂志,2005,2(5):912-915. 被引量:8
  • 2赵明辉,陈旻.小血管炎肾损害[J].中国实用内科杂志,2006,26(3):333-336. 被引量:43
  • 3刘晓华.抗中性粒细胞抗体相关性血管炎的诊断与治疗[J].实用临床医药杂志,2007,11(4):16-19. 被引量:5
  • 4Kanwar YS, Wada J,Sun L,et al. Diabetic nephropathy :mechanisms of -nal disease progression[J]. Exp Biol Med (Maywood),2008,233 ( 1 ) :4-11.
  • 5Abdulahad WH, Stegeman CA, Kallenberg CG. Review article :The roleof CD4(+ ) T ceils in ANCA-associated systemic vasculitis[J]. Nephrology (Carlton) ,2009,14( 1 ) :26-32.
  • 6Koyama A, Yamagata K, Makino H,et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan : etiology, prognosis and treatment diversitv[J]. Clin Exo Neohrol, 2009,13 (6) : 633-650.
  • 7Chen M ,Yu F,Zhang Y,et al. Antineutrophil cytoplasmic autoantibody- associated vaseulitis in older patients[J]. Medicine (Baltimore),2008,87 (4) :203-209.
  • 8Dharmapalaiah C,Watts RA. The role of biologics in treatment of ANCA- associated vasculitis[J]. Mod Rheumatol, 2012,22 (3) : 319-326.
  • 9葛俊波,徐永健内科学[M].8版.北京:人民卫生出版社,2013:797-803.
  • 10Suppiah R,Hadden.RD Peripheral neuropathy in ANCA-associat- ed vasculitis- outcomes from the European Vascufitis Study Group trials[J].Rheumatology (Oxford),2011,50(12):2214-2222.

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部